Results
1 -
10 of
37Christian R. Kowol, Robert Trondl, Vladimir B. Arion, Michael A. Jakupec, Irene Lichtscheidl and Bernhard K. Keppler.
Fluorescence properties and cellular distribution of the investigational anticancer drug Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone) and its zinc(ii), Dalton Trans., 2010, 39, 704. Hu Biao, Wang Bo, Zhao Bing, Guo Qian, Li Zhong-Hua, Zhang Xin-Hui, Liu Guang-Yao, Liu Ying, Tang Ying, Luo Fan, Du Ya, Chen Ya-Xin, Ma Li-Ying, Liu Hong-Min.
Thiosemicarbazone-based selective proliferation inactivators inhibit gastric cancer cell growth, invasion, and migration, MedChemComm, 2017 The maximum tolerated dose and biologic effects of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) in combination with irinotecan for patients with refractory solid tumors, Cancer Chemotherapy and Pharmacology Mechanisms underlying reductant-induced reactive oxygen species formation by anticancer copper(II) compounds, JBIC Journal of Biological Inorganic Chemistry Chemical Papers.
Methyl-2-arylidene hydrazinecarbodithioates: synthesis and biological activity, Chemical Papers Radiation and Altering Clinical Pharmacology, Handbook of Anticancer Pharmacokinetics and Pharmacodynamics Two-Step Procedure for Evaluating Experimentally Induced DNA Damage: Texas Red and Comet Assays, Cervical Cancer Advances in Cervical Cancer and Ongoing Clinical Trials, Gynecological Cancers Comparison of metabolic pathways of different ??-N-heterocyclic thiosemicarbazones, Analytical and Bioanalytical Chemistry Identification of in vitro metabolites of the novel anti-tumor thiosemicarbazone, DpC, using ultra-high performance liquid chromatography?quadrupole-time-of-flight mass spectrometry, Analytical and Bioanalytical Chemistry